The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

And offering a fast-track to approve drugs the Trump administration views as a priority. Welcome to the new Food and Drug ...

The FDA announced a new national priority voucher plan that aims to cut drug review times, while Headspace launches direct-to ...

All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report ...

And more health news stories you need to start your week.

Speaking at BIO 2025, Makary bemoaned what he called “unnecessary steps” and “avoidable delays” in the U.S. regulatory ...

Although the company withheld detailed findings from the study of treatment-resistant depression, analysts at Stifel called ...

Welcome to the new Food and Drug Administration as envisioned by Dr. Marty Makary, who is leading the agency under Health Secretary Robert F. Kennedy Jr. Both men have said they want to overhaul ...

Curay, the FDA’s acting top drug regulator, is stepping down from her post after serving at the agency for more than eight ...

Commissioner Marty Makary and his new vaccines chief boxed longtime bureaucrats out of the recent decision to require more ...

FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...